Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

November 6, 2020

Study Completion Date

December 31, 2020

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DEVICE

Actimetry

Actimetry will be performed at home to measure physical activity, sleep duration and patient chronotype for 7 days.

OTHER

Questionnaires

Patients will complete food and medication intake questionnaires for 7 days.

OTHER

Glucose level and insulin administration

Continuous subcutaneous glucose level (measured by continuous glucose monitor (CGM)) and the insulin doses delivered by the insulin pump will be collected for 7 days .

Trial Locations (1)

38140

AGIRADOM, Meylan

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Icadom

INDUSTRY

collaborator

AGIR à Dom

OTHER

collaborator

CHU Grenoble Alpes

UNKNOWN

lead

Diabeloop

INDUSTRY